Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03458728
Title Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bayer
Indications

Ewing sarcoma

lymphoma

Advanced Solid Tumor

neuroblastoma

rhabdomyosarcoma

osteosarcoma

Therapies

Copanlisib

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.